Secured $26 Million in PIPE Financing Led by a Top-Tier Biotech Investor to Advance Preclinical Programs and Extend Cash RunwayProgressed ...

There are people in Washington whose names rarely appear in the news, yet they have a real influence on the direction of U.S.

Preoperative-optimization-improves-outcomes-through-collaborative-multidisciplinary-perioperative-assessment-and-evidence-based-patient-management ...

Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent Kinase ...

The T-cell factors/lymphoid enhancer-binding factors LEF1 (TCF1α), TCF3 (TCF7L1), TCF4 (TCF7L2), and TCF7 (TCF1) represent the LEF1/TCF family, a group of nuclear DNA-binding transcription factors.

Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and patient-centered outcomes. Pharmacy and precision medicine operations are crucial, ...

A faith-based investment firm partnered with S&P Dow Jones Indices to create a new index and exchange traded fund (ETF) that will cater to evangelical Christian investors. Bountiful Financial and S&P ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

After a first half that saw Publicis Groupe snap up six companies around the world, the advertising giant is continuing its acquisitive streak with its first health-focused buyout of the year.

Publicis Health announced today its “intent to acquire” p-value Group, a medical communications group. Financial terms of the proposed deal were not disclosed. Headquartered in Cedar Knolls, NJ, the ...